Bhubaneswar: Odisha on Friday received 2 lakh more doses of Covishield vaccine.
According to reports, the vaccines will be dispatched to the districts where arrangements are being made to vaccinate beneficiaries above the age of 45.
On Thursday, Additional Chief Secretary, Health, Pradipta Mohapatra had stated during a media briefing that the state government’s priority will be to vaccinate people eligible for the second jab.
The state had requested the Centre to send at least 15 lakh doses of Covishield of the Serum Institute of India by May 15 to cover the population eligible for the 2nd shot.
Mohapatra had said due to acute shortage of Covishield people above 45 years in 30 districts, who have taken the first dose and are now waiting for the second dose. Considering the urgency, there will be no first dose vaccination in the state right now, he had said.
Meanwhile, the state is hopeful of receiving another 5 lakh doses by May 15. The Government is fully prepared to vaccinate even 3 lakh people a day if the required doses arrive.
There are 1500 vaccination centres in state. Around 1.16 crore population of Odisha belongs to 45 plus age group of which 37.5% have been given the first dose.
Of the 43.55 lakh people, 23.43 lakh are waiting for second dose. Of these 23.43 lakh people, 5.96 lakh have taken the second shot and 17.04 lakh people are still in waiting.
Berhampur: Rushikulya river mouth in Odisha’s Ganjam district has emerged as a major rookery for… Read More
Delhi/Mumbai: Twin tragedies in Delhi and Mumbai claimed the lives of a pair of 18-month-old… Read More
Jajpur: A total of 894 ineligible people fraudulently received benefits under an old-age pension scheme… Read More
Bhubaneswar: The International Conference on Recent Advances in Nanomedicine brought together more than 500 participants,… Read More
New Delhi: In a recent statement that has stirred political conversations, Shashi Tharoor reaffirmed his… Read More
Bhopal: Prime Minister Narendra Modi lashed out at critics of the Mahakumbh Mela at a… Read More
This website uses cookies.